secwatch.observer — SEC 8-K summary
======================================

Issuer:     CVS HEALTH Corp (CVS)
CIK:        0000064803
Form:       8-K
Filed at:   2025-02-12T23:59:59+00:00
Accession:  0000064803-25-000006
Event type: earnings
Sentiment:  negative
Materiality: 0.80
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

CVS Health Q4 revenue up 4.2% to $97.7B, adjusted EPS falls 44% to $1.19; FY25 guidance below consensus
--------------------------------------------------------------------------------

- GAAP diluted EPS $1.30 (down $0.28 YoY); adjusted EPS $1.19 (down $0.93 YoY) on Health Care Benefits weakness.
- Full-year 2024 total revenues $372.8B (+4.2% YoY); GAAP diluted EPS $3.66, adjusted EPS $5.42.
- Health Care Benefits segment hurt by continued utilization pressure and unfavorable Medicare Advantage star ratings.
- 2025 guidance: GAAP diluted EPS $4.58-$4.83; adjusted EPS $5.75-$6.00; cash flow from ops ~$6.5B.
- Pharmacy & Consumer Wellness segment showed growth, but overall earnings pressured by insurance challenges.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/64803/000006480325000006/0000064803-25-000006-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/64803/000006480325000006/cvs-20250212.htm
  HTML page:      https://secwatch.observer/filing/0000064803-25-000006

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer